[Pneumocystosis during HIV infection]
M El Fane1, M Sodqi1, A Oulad Lahsen1
1Service des maladies infectieuses, CHU Ibn-Rochd, Casablanca, Maroc.
Revue De Pneumologie Clinique
|June 29, 2016
Summary
Pneumocystis pneumonia, caused by Pneumocystis jirovecii fungus, is a significant threat in immunocompromised patients, particularly those with HIV/AIDS. Early diagnosis and treatment with trimethoprim-sulfamethoxazole are crucial for recovery.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Immunology
Background:
- Pneumocystosis is an opportunistic infection caused by Pneumocystis jirovecii.
- It primarily affects individuals with compromised cellular immunity, notably HIV-infected patients.
- Despite advances, Pneumocystis pneumonia (PCP) remains a leading cause of mortality and an AIDS-defining illness.
Purpose of the Study:
- To review the characteristics, diagnosis, and treatment of Pneumocystis pneumonia.
- To highlight the importance of early diagnosis and management in HIV-infected individuals.
Main Methods:
- Review of radiological findings, typically diffuse interstitial pneumonia.
- Diagnostic confirmation through detection of P. jirovecii in bronchoalveolar lavage (BAL) samples.
- Utilizing staining techniques, immunofluorescence, colorimetric tests, and PCR for rapid and accurate diagnosis.
Main Results:
- Pneumocystis pneumonia presents radiologically as diffuse interstitial pneumonia.
- Polymerase chain reaction (PCR) enhances diagnostic speed and accuracy.
- Trimethoprim-sulfamethoxazole is the standard effective treatment, leading to favorable recovery.
Conclusions:
- Pneumocystis pneumonia remains a critical opportunistic infection in HIV-positive individuals.
- Prompt diagnosis and effective treatment with trimethoprim-sulfamethoxazole are vital.
- Early HIV diagnosis and antiretroviral therapy are key to reducing PCP incidence.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.7K
08:14An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
10.7K
Related Concept Videos
01:30Pneumonia I: Introduction
1.2K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
01:29Pneumonia II: Pathophysiology
3.9K
The pathophysiology of pneumonia involves the following steps:
3.9K
01:30Pneumonia III: Complications and Assessment
1.1K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
01:29Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
01:30Pneumonia V: Nursing management and Prevention
3.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
01:28Pneumonia IV: Management
1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K